The Link Between Obesity And Vitamin D in Bariatric Patients With Omega-loop Bypass Surgery

NCT02092376 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2016-07-14

No results posted yet for this study

Summary

The aim of the study is to increase vitamin D concentrations or to keep it on high level, respectively, by supplementing with vitamin D3 in a different dose regime, and to improve the overall health status in bariatric patients. In this project, the vitamin D status, the parameters of inflammation, bone turnover, insulin resistance, liver and depression score of bariatric patients are expected to improve, due to supplementation of a loading dose compared to the standard therapy.

Conditions

  • Bariatric Surgery Candidate

Interventions

DRUG

Cholecalciferol

DRUG

Placebo

Sponsors & Collaborators

  • Maria Luger

    lead OTHER

Principal Investigators

  • Bernhard Ludvik, M.D. · Division of Endocrinology & Metabolism, Department of Internal Medicine III, Medical University of Vienna

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2015-10-31
Completion
2016-06-30

Countries

  • Austria

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02092376 on ClinicalTrials.gov